The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sellati, T. J.
Right arrow Articles by Radolf, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sellati, T. J.
Right arrow Articles by Radolf, J. D.
The Journal of Immunology, 1999, 163: 2049-2056.
Copyright © 1999 by The American Association of Immunologists

Activation of Human Monocytic Cells by Borrelia burgdorferi and Treponema pallidum Is Facilitated by CD14 and Correlates with Surface Exposure of Spirochetal Lipoproteins1

Timothy J. Sellati2,*, Deborah A. Bouis2,*, Melissa J. Caimano*, J. Amelia Feulner, Christopher Ayers*, Egil Lien{ddagger} and Justin D. Radolf3,*

Departments of * Internal Medicine and {dagger} Microbiology and the {ddagger} Cell and Molecular Biology Graduate Program, University of Texas Southwestern Medical Center, Dallas, TX 75235; and § Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine/Boston Medical Center, Boston, MA 02118


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Here we examined the involvement of CD14 in monocyte activation by motile Borrelia burgdorferi and Treponema pallidum. B. burgdorferi induced secretion of IL-8 by vitamin D3-matured THP-1 cells, which was inhibited by a CD14-specific mAb known to block cellular activation by LPS and the prototypic spirochetal lipoprotein, outer surface protein A. Enhanced responsiveness to B. burgdorferi also was observed when THP-1 cells were transfected with CD14. Because borreliae within the mammalian host and in vitro-cultivated organisms express different lipoproteins, experiments also were performed with "host-adapted" spirochetes grown within dialysis membrane chambers implanted into the peritoneal cavities of rabbits. Stimulation of THP-1 cells by host-adapted organisms was CD14 dependent and, interestingly, was actually greater than that observed with in vitro-cultivated organisms grown at either 34°C or following temperature shift from 23°C to 37°C. Consistent with previous findings that transfection of Chinese hamster ovary cells with CD14 confers responsiveness to LPS but not to outer surface protein A, B. burgdorferi failed to stimulate CD14-transfected Chinese hamster ovary cells. T. pallidum also activated THP-1 cells in a CD14-dependent manner, although its stimulatory capacity was markedly less than that of B. burgdorferi. Moreover, cell activation by motile T. pallidum was considerably less than that induced by treponemal sonicates. Taken together, these findings support the notion that lipoproteins are the principle component of intact spirochetes responsible for monocyte activation, and they indicate that surface exposure of lipoproteins is an important determinant of a spirochetal pathogen’s proinflammatory capacity.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Borrelia burgdorferi and Treponema pallidum subpecies pallidum are the etiologic agents of Lyme disease and venereal syphilis, respectively (1, 2). Although transmitted differently (tick bite vs sexual transmission), these multisystem diseases share many clinical and histopathological features; moreover, in both disorders, host injury is presumed to result from the inflammatory response to intrinsic spirochetal components (1, 2). It is well established that spirochetes lack the potent proinflammatory molecule LPS found in the outer membranes of Gram-negative bacteria (3, 4, 5). However, they do possess abundant lipoproteins (3, 4, 6, 7), and there is now a substantial body of evidence that these molecules act as major proinflammatory agonists with the ability to influence both innate and adaptive immune responses during spirochetal infection (8, 9, 10, 11, 12, 13, 14, 15).

The well characterized LPS receptor, CD14, has been described as a pattern recognition molecule for diverse bacterial components that trigger innate immune responses (16, 17, 18). CD14 exists as a 55-kDa glycosylphosphatidylinositol-linked protein (membrane CD14 (mCD14)4) on the surface of macrophages and neutrophils (19, 20, 21) and as a soluble protein (sCD14) in serum (22). The soluble form of CD14 facilitates the activation of cells, such as endothelial cells, which lack mCD14 (23, 24). Recent in vitro studies implicate both forms of CD14 in the inflammatory response to spirochetal lipoproteins, although there appear to be distinctions between the CD14-dependent pathways used by LPS and spirochetal lipoproteins (25, 26, 27). The lipid moiety of lipoproteins is crucial for binding to CD14 as well as for cell activation (12, 27). However, an apparent paradox arises from the fact that these lipid components are sequestered within the spirochetal membrane (28), where they should be inaccessible for binding to CD14. Topological concerns are even more pertinent with T. pallidum, as evidence to date indicates that it has a paucity of lipoproteins on its surface (29, 30). Nevertheless, motile B. burgdorferi and T. pallidum do activate innate immune effector cells (31, 32, 33), although it remains to be proven that these effects are lipoprotein-mediated.

As an initial step toward addressing this issue, and to employ in vitro conditions that more closely resemble the in vivo situation, we examined monocyte activation by motile B. burgdorferi and T. pallidum. The findings reported here indicate that CD14 does indeed facilitate monocyte activation by spirochetes, and they also support the hypothesis that lipoproteins are the principle component of intact organisms in this process. Also of considerable interest was the observation that surface exposure of lipoproteins is an important determinant of a spirochetal pathogen’s stimulatory capacity. With this information, we are better positioned to understand how pathogenic spirochetes engage host immune defenses during infection.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

Salmonella minnesota R5 LPS (Sigma, St. Louis, MO) was suspended in 0.1% triethylamine adjusted to pH 8.0 with 100 mM Tris-HCl. Dilutions of LPS were made with HNEB buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 0.1 mM EDTA, and 0.03% BSA). 1,25-dihydroxyvitamin D3 was obtained from Biomol Research Laboratories (Plymouth Meeting, PA). G-418 sulfate was purchased from Mediatech (Herndon, VA). Great care was taken during the preparation of all buffers and reagents to minimize contamination with environmental LPS by using baked glassware, disposable plasticware, and pyrogen-free H2O.

Bacterial strains

Low-passage B. burgdorferi 297 (34) was obtained from Russell Johnson (University of Minnesota). The B31-type strain of B. burgdorferi MedImmune clone (4) was provided by Raju Lathigra (MedImmune, Gaithersburg, MD). Spirochetes were cultivated in vitro at 23°C, 34°C, or 37°C after temperature shift from 23°C as described previously (35). All experiments were performed with spirochetes that had been passaged no more than five times in Barbour-Stoenner-Kelly (BSK)-H medium (Sigma). With both strains, infectivity was periodically assessed by low-dose (1 x 103 borreliae) intradermal needle inoculation of 3-wk-old C3H/HeJ mice (The Jackson Laboratory, Bar Harbour, ME) and culture of ear punch biopsies 2 wk later. T. pallidum (Nichols) was propagated by intratesticular inoculation of adult New Zealand White rabbits as previously described (36). Treponemes were extracted from infected testes in RPMI 1640 medium (Mediatech) supplemented with 10% heat-inactivated FBS (heated for 30 min at 56°C) (Mediatech) and separated from testicular tissue debris by low-speed centrifugation (350 x g for 10 min). In all experiments, spirochetes were enumerated by dark-field microscopy using a Petroff Hausser counting chamber (Hausser Scientific Company, Horsham, PA).

Cultivation of B. burgdorferi B31 within dialysis membrane chambers (DMCs) implanted into rabbits

To generate increased quantities of host-adapted spirochetes, we modified the procedure of Akins et al. (37). Briefly, Spectra/Por 6 dialysis membranes (Fisher Scientific, Pittsburgh, PA) with a molecular mass cut-off of 8000 Da were prewashed with Milli-Q water and sterilized by boiling in 1 mM EDTA and then in Milli-Q water for 20 min each. Dialysis bags were submersed in BSK-H medium overnight at 4°C. After tying one end, each bag was filled with 25 ml of BSK-H medium containing 2.5 x 104 organisms from a mid-log phase culture grown at 23°C. Tubing was then tied and excess membrane was removed from both ends. New Zealand White rabbits were anesthetized with 3.5% isoflurane, and three DMCs per rabbit were implanted into the peritoneal cavities using strict aseptic technique. Eight to 10 days postimplantation, the chambers were harvested. The outside of each chamber was washed extensively with BSK-H medium and the contents were removed via syringe aspiration.

Purification of native outer surface protein A (nOspA) from B. burgdorferi

NOspA was affinity purified from B. burgdorferi strain TI1-EV as previously described (38) and stored in 33 mM Tris, pH 7.4, 1.6 mM NaCl, and 20 mM n-octyl-ß-glucoside at -70°C. Preparations of nOspA contained <=12 pg LPS/µg protein as measured by the QCL-1000 quantitative, chromogenic Limulus amebocyte lysate assay (BioWhittaker, Walkersville, MD).

SDS-PAGE and two-dimensional nonequilibrium pH gel electrophoresis (2D-NEPHGE)

For SDS-PAGE, samples were boiled for 5 min in final sample buffer (62.5 mM Tris-HCl, 2% SDS, 10% glycerol, 5% 2-ME, 0.001% bromophenol blue) and electrophoresed through 4.5% stacking and 12.5% resolving gels before staining with silver. 2D-NEPHGE was performed as described by O’Farrell et al. (39). Briefly, whole-cell lysates were subjected to first dimension NEPHGE for 5 h at 400 V in 11-cm tube gels consisting of 4% pH 5–7 and 1% pH 3.5–10 ampholines (Bio-Rad, Hercules, CA). For the second dimension, tube gels were overlaid on top of 2.4% stacking and 12.5% separating SDS-polyacrylamide slab gels. Apparent isoelectric point (pI) values were determined by adding pI standards (Bio-Rad) to one tube gel and subjecting it to first- and second-dimension electrophoresis under the same conditions.

Cell lines

The human promyelomonocytic cell line THP-1 (40) was maintained in RPMI 1640 medium (Mediatech) containing 2 mM L-glutamine and supplemented with 10% heat-inactivated FBS, 100 U of penicillin per ml, and 100 µg of streptomycin per ml. Cells were differentiated by preincubation with 100 nM vitamin D3 for 72–96 h before stimulation by LPS, nOspA, B. burgdorferi, and T. pallidum. CD14- and Rous sarcoma virus vector-transfected THP-1 cells (26, 41), kindly provided by Richard Ulevitch (Scripps, La Jolla, CA), were cultured in the continuous presence of 0.5 mg/ml (active drug) of the aminoglycoside G-418 sulfate to ensure the maintenance of stably transfected DNA conferring neomycin resistance. G-418 sulfate was removed 24 h before experimentation. Chinese hamster ovary (CHO) K1 cells stably cotransfected with pCEP4 (Invitrogen, San Diego, CA), which constitutively expressed the gene for human CD14 from a CMV promoter, and pUMS(ELAM)-Tac, which contains the gene for CD25 under the control of an NF-{kappa}B-inducible E-selectin promoter (3E10 cells) (42), were grown in Ham’s F12 medium containing 10% heat-inactivated FBS and 400 U of hygromycin B per ml.

Cell activation experiments

THP-1 cells were seeded in 24-well flat-bottom tissue culture plates (Becton Dickinson Labware, Lincoln Park, NJ) at a density of 2.5 x 105 cells/ml and were maintained at 37°C in a humidified atmosphere of 5% CO2 and air. Cells were then stimulated for 3 h with LPS, nOspA, B. burgdorferi, or T. pallidum, and culture supernatants were assayed for IL-8 using the Duoset ELISA development system from R&D Systems (Minneapolis, MN). For Ab blocking experiments, vitamin D3-matured THP-1 cells (2.5 x 105 cells in 0.1 ml) were preincubated at room temperature for 15 min with 10 µg/ml of murine mAbs directed against CD14 (60bca and 63D3; both IgG1) before the addition of agonists. For sonication experiments, T. pallidum were washed twice in PBS, pH 7.2, and ruptured with a sonic dismembrator (Fisher Scientific); the efficiency of sonication was verified by dark-field microscopy. For analyzing cell activation by B. burgdorferi and T. pallidum based upon total protein content, equivalent numbers of organisms were sonicated as described above and protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad). 3E10 cells were seeded at a density of 2 x 105 cells per well in 24-well plates; the following day cells were washed twice with medium and stimulated for 8 h with 100 ng/ml of LPS, 1 µg/ml of nOspA, or graded ratios of B. burgdorferi B31. The cells were then washed and incubated with PE-conjugated mAb directed against human CD25 (Becton Dickinson Immunocytometry Systems, San Jose, CA) for FACS analysis. In all activation and blocking experiments, spirochetes were >=90% viable (i.e., motile) at the end of the experiment, as assessed by dark-field microscopy.

Statistics

The two-tailed Student’s t test or a one-way ANOVA with a Tukey-Kramer multiple comparisons post test was performed using GraphPad InStat version 3.00 for Windows 95 (GraphPad Software, San Diego, CA). A value of p < 0.05 was used as the {alpha} value to determine statistical significance for all analyses.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CD14 expression enhances the responsiveness of human monocytic cells to motile B. burgdorferi

In a previous study (26), functional blockade of CD14 by polyclonal anti-CD14 Abs was one of several strategies used to demonstrate that monocytic cell activation by spirochetal lipoproteins is facilitated by CD14. To correlate lipoprotein- and spirochete-mediated activation, we reasoned that it would be useful to determine whether both interact with the same domain on CD14. Recently, two groups have independently shown that anti-CD14 mAb 60bca, which is known to block LPS-mediated monocytic and endothelial cell activation, also blocks cellular activation by borrelial lipoproteins (25, 27). In preliminary studies, we also observed that this Ab blocked secretion of the neutrophil chemoattractant IL-8 by vitamin D3-matured THP-1 cells over a range of nOspA concentrations, whereas 63D3, a known LPS-nonblocking mAb (43), was without effect (data not shown). We next examined the ability of virulent B. burgdorferi to stimulate vitamin D3-matured cells. As shown in Fig. 1GoA, B. burgdorferi induced the secretion of IL-8 in a dose-dependent fashion; significant cellular activation occurred with a single spirochete per cell. Interestingly, activation of undifferentiated cells was observed at spirochete-to-cell ratios of 100:1 and 1000:1, although the IL-8 levels were significantly less than those produced by vitamin D3-matured cells under the same conditions. Thus, cellular activation by B. burgdorferi also may have a CD14-independent component, a phenomenon previously observed at relatively high concentrations of spirochetal lipoprotein/lipopeptide agonists (26). Activation of vitamin D3-matured cells by B. burgdorferi was substantially blocked by 60bca, whereas 63D3 was noninhbitory (Fig. 1GoB), thereby demonstrating that the cellular response at this spirochete-to-cell ratio (10:1) was largely CD14 dependent. The inability of the Ab to completely block IL-8 production also was consistent with the notion of the existence of a minor CD14-independent component. We previously demonstrated that transfection of undifferentiated THP-1 cells with CD14 confers enhanced responsiveness to spirochetal lipoproteins as well as to LPS (26). To confirm the Ab blocking results, we investigated whether CD14 transfected THP-1 cells also manifest enhanced responsiveness to live spirochetes. Fig. 2Go shows that at spirochete-to-cell ratios above 1:1, the CD14-transfected cells produced significantly greater amounts of IL-8 than did cells transfected with the empty vector. As before, a lesser degree of stimulation was observed in the absence of CD14 expression.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 1. B. burgdorferi-induced secretion of IL-8 by vitamin D3-matured THP-1 cells is inhibited by mouse anti-human CD14 mAb 60bca. A, IL-8 production by undifferentiated and vitamin D3-matured cells incubated with increasing numbers of B. burgdorferi 297. B, IL-8 production by undifferentiated THP-1 cells and vitamin D3-matured cells preincubated with medium alone, 10 µg/ml 60bca, or 10 µg/ml 63D3 before the addition of spirochetes at a 10:1 ratio. Shown are the mean ± SE of duplicate determinations for six (A) and the mean ± SD for two (B) independent experiments. Asterisks indicate results that are significantly different from their undifferentiated counterparts.

 


View larger version (11K):
[in this window]
[in a new window]
 
FIGURE 2. Transfection of THP-1 cells with CD14 enhances activation by B. burgdorferi. IL-8 production by THP-1 cells transfected with empty vector alone or CD14 following incubation for 3 h with increasing numbers of B. burgdorferi 297. Shown are the means ± SE of duplicate determinations for three independent experiments. Asterisks indicate results that are significantly different from their Rous sarcoma virus-transfected counterparts.

 
B. burgdorferi cultivated in DMCs also activate vitamin D3-matured THP-1 cells in a CD14-dependent manner

Because the antigenic composition of B. burgdorferi during mammalian infection differs from that of in vitro-cultivated organisms (35, 44), experiments performed with in vitro-cultivated spirochetes may not accurately reproduce pathogen-host cell interactions occurring in vivo. Recently, we showed that cultivation of spirochetes within DMCs implanted into the peritoneal cavities of rats generates spirochetes that more closely resemble the host-adapted phenotype (37). Therefore, it was of considerable interest to compare monocytic cell activation by chamber- and in vitro-grown organisms. To obtain the numbers of host-adapted spirochetes required for these studies, we modified our original system by cultivating borreliae within DMCs implanted into rabbits. Fig. 3Go demonstrates that rabbit DMC-cultivated B. burgdorferi B31 expressed greatly diminished amounts of OspA and OspB and greatly increased amounts of OspC when compared with organisms grown in BSK-H at 34°C or following temperature shift from 23°C to 37°C (a control for the higher ambient temperature within the rabbit peritoneal cavity). Furthermore, as previously described for B. burgdorferi 297 (37), other differences in polypeptide composition were readily discernible by both SDS-PAGE (Fig. 3Go) and 2D-NEPHGE analysis (data not shown). Spirochetes cultivated at 34°C or following temperature shift induced similar levels of IL-8 secretion by vitamin D3-matured THP-1 cells, and these levels were roughly equivalent to those observed in earlier experiments with in vitro-cultivated B. burgdorferi 297 (compare Fig. 1GoA and Fig. 4GoA). In contrast, DMC-cultivated organisms stimulated significantly greater IL-8 secretion than either population of in vitro-cultivated organisms (Fig. 4GoA). To assess the contribution of CD14 to this response, blocking experiments were performed with mAbs 60bca and 63D3. Fig. 4GoB shows that 60bca reduced IL-8 secretion to the levels typically observed with undifferentiated cells, whereas 63D3 was noninhibitory.



View larger version (117K):
[in this window]
[in a new window]
 
FIGURE 3. Polypeptide profiles of in vitro- and DMC-cultivated B. burgdorferi. Whole-cell lysates from B. burgdorferi B31 (2 x 107) grown in vitro at 23°C, after temperature shift to 37°C, within DMCs or in vitro at 34°C were separated by SDS-PAGE and stained with silver. Several well-characterized borrelial proteins are indicated on the right and molecular mass markers in kilodaltons are shown on the left.

 


View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 4. Activation of vitamin D3-matured THP-1 cells by DMC-cultivated B. burgdorferi is inhibited by an anti-CD14 mAb. A, IL-8 production by undifferentiated and vitamin D3-matured THP-1 cells incubated for 3 h with increasing numbers of B. burgdorferi B31 grown at 34°C, at 37°C following temperature shift, or within DMCs. Asterisks indicate results that are significantly different from their 34°C counterparts. B, IL-8 production by undifferentiated and vitamin D3-matured cells preincubated with medium alone, 10 µg/ml 60bca, or 10 µg/ml 63D3 before 3h of incubation with DMC-grown spirochetes. Shown are results representative of three (A) and two (B) independent experiments.

 
Transfection of CHO cells with CD14 fails to confer responsiveness to B. burgdorferi

Unlike THP-1 cells, tranfection of CHO cells with CD14 does not confer responsiveness to spirochetal lipoproteins as it does to LPS (26). This important observation was one of several lines of evidence suggesting that spirochetal lipoproteins and LPS use disparate transmembrane signaling elements immediately downstream from CD14 (11, 12, 38). In light of the above findings with CD14-transfected THP-1 cells, we next sought to determine the effect of CD14 transfection on the responsiveness of CHO cells to live spirochetes. For these experiments, we used a CHO cell line cotransfected with CD14 (expressed constitutively) and the Tac Ag (CD25) under the control of the NF-{kappa}B-inducible E-selectin promoter (3E10 cells) (42). In contrast to LPS, both B. burgdorferi and nOspA failed to induce the expression of CD25 in 3E10 cells (Fig. 5Go).



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 5. CD14-transfected CHO cells are activated by LPS but not by nOspA or B. burgdorferi. 3E10 cells were incubated for 8 h with LPS (100 ng/ml), nOspA (1 µg/ml), or B. burgdorferi B31 at a 1000:1 spirochete-to-cell ratio. The cells were harvested, stained with PE-CD25 mAb, and analyzed for reporter gene expression by FACS. Thin and thick lines represent unstimulated and stimulated cells, respectively. Shown are results representative of three independent experiments.

 
Motile T. pallidum activate vitamin D3-matured THP-1 cells in a CD14-dependent manner but are markedly less stimulatory than B. burgdorferi

T. pallidum is similar to B. burgdorferi in that it contains abundant lipoproteins capable of activating monocytic cells in a CD14-enhanced fashion (11, 12, 26, 38). However, unlike B. burgdorferi, T. pallidum lipoproteins are predominantly subsurface (29, 30) and thus may not be as accessible to CD14 as their borrelial counterparts. To address this issue, we examined the ability of motile T. pallidum to stimulate THP-1 cells. Activation of vitamin D3-matured cells was observed only at 1000 treponemes per cell (Fig. 6GoA); blocking with mAb 60bca confirmed that this response was facilitated by CD14 (Fig. 6GoB). Comparison of Figs. 1GoA and 6A highlights the much lower stimulatory capacity of T. pallidum as compared with B. burgdorferi. We next considered the possibility that the difference in IL-8 secretion induced by the two spirochetes was due to the larger size of B. burgdorferi rather than to their different molecular architectures. To evaluate this, experiments were conducted in which the input spirochete-to-cell ratios were plotted by protein content. As shown in Fig. 7GoA, B. burgdorferi was more stimulatory than T. pallidum over the entire range of protein concentrations evaluated. If the relatively poor stimulatory activity of T. pallidum were due to its paucity of surface-exposed lipoproteins, one would predict that T. pallidum sonicates would be more stimulatory than intact organisms. As shown in Fig. 7GoB, this was indeed the case when IL-8 secretion induced by intact treponemes and equivalent cell lysates was directly compared. It is noteworthy that the cellular response to treponemal sonicate plateaus at ratios above 10 organisms/cell; a plateau in responsiveness also was observed when purified lipoproteins or synthetic/lipopeptides were used in stimulation assays (26).



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 6. Activation of monocytic cells by T. pallidum is facilitated by CD14. A, IL-8 production by undifferentiated and vitamin D3-matured THP-1 cells incubated with increasing numbers of motile T. pallidum. Shown are the mean ± SE of duplicate determinations for three independent experiments. B, IL-8 production by undifferentiated cells and vitamin D3-matured cells preincubated with medium alone, 10 µg/ml 60bca, or 10 µg/ml 63D3 before the addition of LPS (10 ng/ml) or spirochetes at a 1000:1 ratio. Shown are the means ± SE of duplicate determinations for three independent experiments. Asterisks indicate results that are significantly different from their undifferentiated counterparts.

 


View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 7. Subsurface localization of lipoprotein explains the relatively poor stimulatory activity of T. pallidum as compared with B. burgdorferi. A, Comparison of IL-8 production by vitamin D3-matured THP-1 cells incubated with motile B. burgdorferi and T. pallidum normalized for protein content. The data points represent the protein contents of 2.5 x 104, 2.5 x 105, 2.5 x 106, 2.5 x 107, and 2.5 x 108 organisms. B, IL-8 production by undifferentiated and vitamin D3-matured cells in response to intact T. pallidum or sonicated T. pallidum. Shown are the means ± SE of duplicate determinations for three independent experiments. Asterisks indicate results that are significantly different from the same cells incubated with an equivalent number of motile spirochetes.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CD14 has been designated a pattern recognition receptor by virtue of its ability to mediate monocytic and endothelial cell activation in response to myriad bacterial cell wall products in addition to LPS (17, 18, 45). From this work has arisen the notion that CD14-mediated interactions are a critical first step in the elicitation of innate immune responses to bacterial pathogens (18). However, because of the complexity of bacterial cell wall architecture, it cannot be assumed that all cell wall components are equally accessible to CD14. For this reason, in vitro studies using purified components eventually must be validated using the intact organism from which the cell wall component was derived. Along these lines, studies from several laboratories have demonstrated that spirochetal lipoproteins and/or synthetic lipopeptides have proinflammatory activities (8, 9, 10, 11, 12, 13, 14, 15, 32, 38), while others have shown that motile spirochetes also are capable of activating innate immune effector cells (31, 32, 33). The recent finding that spirochetal lipoproteins/lipopeptides activate cells via a distinctive CD14-dependent pathway (26) provided us with a convenient starting point for relating these two sets of experimental observations.

Here we used two different approaches to demonstrate that induction of IL-8 secretion by monocytic cells during incubation with viable spirochetes is facilitated by CD14. The first used vitamin D3-matured THP-1 cells. Previous studies have shown that vitamin D3 maturation induces expression of surface-bound CD14 and that this results in enhanced cellular responsiveness to both LPS and spirochetal lipoproteins (26, 38, 46, 47). Because the effects of vitamin D3 are pleiotropic (48, 49), we confirmed the CD14 dependence of the response with a LPS-blocking anti-CD14 mAb, which also antagonized cellular activation by the prototypical spirochetal lipoprotein OspA (25, 27). Although the epitope on CD14 recognized by 60bca has not been mapped to a specific region of CD14 required for LPS-mediated signaling (50, 51, 52), this result is consistent with the finding that LPS and nOspA appear to bind to similar domains on CD14 (27). To confirm the blocking studies, we also examined THP-1 cells transfected with CD14; as previously observed with lipoproteins/lipopeptides (26), responsiveness was significantly enhanced in the transfected cells. Lastly, we noted that CHO cells transfected with CD14, while sensitive to LPS, failed to respond to either spirochetes or nOspA, indicating that both spirochetes and nOspA use a CD14-dependent signaling pathway(s) different from that used by LPS. Although these results do not constitute definitive evidence that lipoproteins are the principal stimulatory component of live spirochetes, they are entirely consistent with this notion.

Lipid modification is essential for CD14-dependent lipoprotein activation and probably reflects binding of the agonist to an amphipathic pocket within the receptor. However, because the lipid moieties of lipoproteins are stably embedded within the spirochetal membrane (28), it is not immediately clear how this binding interaction occurs. At least three testable scenarios, which are not mutually exclusive, can be envisioned to explain this apparent paradox. The first is that lipoproteins shed from the surface of the bacterium or released from dying organisms bind to CD14 and activate the cell. If this is correct, then binding of the spirochete to the monocytic cell surface should not be necessary for activation. Second, lipoproteins may be directly removed from the spirochetal membrane, thereby overcoming a thermodynamically stable configuration within the lipid bilayer. This process also might not require direct spirochete-cell interactions; alternatively, outer membrane perturbations caused when organisms bind to the monocytic cell surface could facilitate transfer of lipoproteins to CD14. Lastly, degradation of lipoproteins following uptake of spirochetes into phagolysosomes could liberate biologically active lipopeptides, which then interact with CD14. Consistent with this notion are the observations that synthetic lipopeptides and lipopeptides generated by extensive proteolysis of native proteins retain proinflammatory activity (11, 12, 27) and that CD14 is found within endocytic structures (53). Interestingly, a similar topologic problem pertains to LPS given that its biologically active component, lipid A, also is stably inserted into Gram-negative bacterial outer membranes (54). Although the mechanism by which outer membrane-associated LPS engages CD14 has not been elucidated, studies suggest that it may be more potent for signaling than free LPS (55, 56). Ongoing efforts to distinguish among these mechanisms with respect to spirochetal lipoproteins could have broader implications for other disorders, including Gram-negative bacterial sepsis and septic shock (57).

The topological considerations for T. pallidum are even more complex given its paucity of surface-exposed lipoproteins (29, 30). In head-to-head comparisons, purified T. pallidum cell lysates, lipoproteins, and synthetic lipopeptides are similar in potency to each other and to their borrelial counterparts (11, 12, 26). On the other hand, the in vitro experiments reported here clearly demonstrate that intact treponemes are markedly less stimulatory than either treponemal sonicates or intact B. burgdorferi and that differences in cell activation between T. pallidum and B. burgdorferi could not be attributed to the larger size of the latter. We believe that the disparate outer membrane architectures of the two organisms is the most straightforward explanation for their inherently different stimulatory capacities. It should be noted that these findings also lend additional, albeit indirect, support to the conjecture that lipoproteins are responsible for monocyte activation by intact spirochetes. Two additional implications of the disparity between T. pallidum and B. burgdorferi need to be mentioned. First, compared with B. burgdorferi, cellular activation by T. pallidum should be relatively dependent upon uptake and processing by professional phagocytes. Second, although constitutional manifestations occur with both syphilis and Lyme disease (1, 2), there is a general impression that they are more common and severe in Lyme disease despite its paucibacillary nature (2, 34, 58). A greater ability of intact borreliae to induce cytokine production by innate immune effector cells could underlie, at least in part, this clinical observation. T. pallidum’s ability to evade phagocytosis by macrophages, even in the presence of opsonizing Abs (30, 59, 60), would further serve to diminish cytokine production during syphilitic infection.

T. pallidum exists only within a mammalian host and, therefore, is perpetually host adapted. Consequently, one can be highly certain that in vitro experiments with the syphilis spirochete are examining the bacterium in the antigenic state actually encountered by the host during infection. B. burgdorferi, on the other hand, undergoes major shifts in antigenic composition as it cycles between arthropod and mammal (35, 44). Based upon their expression of proteins such as OspA, OspB, and Lp6.6 and their decreased expression of OspC, in vitro-cultivated organisms appear to more closely resemble the phenotype within ticks. These considerations sound a cautionary note regarding tissue culture studies conducted with in vitro-cultivated organisms. To circumvent this problem, we also conducted studies with DMC-grown organisms; surprisingly, we found that spirochetes cultivated in this manner were actually more stimulatory than their in vitro-grown counterparts. Although these host-adapted organisms expressed much lower levels of OspA and OspB, the up-regulation of other lipoprotein Ags, most notably OspC, probably explains their greater stimulatory capacity. This finding also potentially relates to the prominence of constitutional symptoms in Lyme disease (2).

For many years it has been postulated that a transmembrane protein immediately downstream from CD14 transduces the signal from this glycosylphosphatidylinositol-linked polypeptide after binding of LPS or other agonists (18, 61). Recent findings implicate one or more members of the Toll-like receptor (TLR) protein family as the long-sought signaling element(s) (62, 63, 64, 65, 66). Our current working hypothesis is that the use of different TLR proteins explains the previously observed dichotomy between LPS- and lipoprotein-mediated CD14-dependent signaling (26). The use of different TLRs as downstream signaling elements provides a potential explanation for other observations made by us here and in a prior communication (26). For example, it predicts that CHO cells constitutively express the LPS-specific TLR but not that used by spirochetal lipoproteins, thereby accounting for the lack of responsiveness of CD14-transfected CHO cells to lipoproteins and spirochetes. Furthermore, the consistently greater responsiveness of vitamin D3-matured THP-1 cells, as compared with CD14-transfected THP-1 cells, could reflect vitamin D3-induced expression of TLRs as well as CD14. Lastly, the CD14-independent activation observed with either higher dosages of lipoproteins/lipopeptides (26) or higher spirochete-to-cell ratios could reflect the bypassing of CD14 in favor of a direct interaction with one or more TLRs. On the other hand, the possibility also exists that activation of undifferentiated THP-1 cells reflects a distinct signaling pathway. Examination of the role of TLRs in these signaling events will enable us to address the above issues while further exploring the relationship(s) between lipoprotein- and spirochete-mediated cellular activation.


    Acknowledgments
 
We thank Kenneth W. Bourell for superb technical assistance with small animal surgery, imaging, and computer graphics.


    Footnotes
 
1 This work was supported by Public Health Service Grants AI-29735 and AI-38894 and a grant from the Advanced Technology Program of the Texas Higher Education Coordinating Board (J.D.R.). T.J.S. was supported by National Research Service Award AI-09973 from National Institute of Allergy and Infectious Diseases and by a research fellowship award from the Arthritis Foundation. M.J.C. was supported by Molecular Microbiology Training Grant AI-07520 from National Institute of Allergy and Infectious Diseases, and E.L. was supported by the Research Council of Norway and the Norwegian Cancer Society. Back

2 T.J.S. and D.A.B. contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Justin D. Radolf, Center for Microbial Pathogenesis, University of Connecticut Health Center, Farmington, CT 06030. E-mail address: Back

4 Abbreviations used in this paper: mCD14, membrane CD14; nOspA, native outer surface protein A; CHO, Chinese hamster ovary; BSK, Barbour-Stoenner-Kelly; DMCs, dialysis membrane chambers; sCD14, soluble CD14; 3E10, CHO-CD14-Tac reporter cell line; 2D-NEPHGE, two-dimensional nonequilibrium pH gel electrophoresis; TLRs, Toll-like receptors. Back

Received for publication March 12, 1999. Accepted for publication May 27, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Lukehart, S. A., K. K. Holmes. 1994. Syphilis. eds. Harrison’s Principles of Internal Medicine, 13th Ed 726. McGraw Hill Book Company, New York.
  2. Steere, A. C.. 1989. Lyme disease. N. Engl. J. Med. 321:586.[Abstract]
  3. Fraser, C. M., S. J. Norris, G. M. Weinstock, O. White, G. C. Sutton, R. Dodson, M. Gwinn, E. K. Hickey, R. Clayton, K. A. Ketchum, et al 1998. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375.[Abstract/Free Full Text]
  4. Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, et al 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580.[Medline]
  5. Takayama, K., R. J. Rothenberg, A. G. Barbour. 1987. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55:2311.[Abstract/Free Full Text]
  6. Brandt, M. E., B. S. Riley, J. D. Radolf, M. V. Norgard. 1990. Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect. Immun. 58:983.[Abstract/Free Full Text]
  7. Chamberlain, N. R., M. E. Brandt, A. L. Erwin, J. D. Radolf, M. V. Norgard. 1989. Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect. Immun. 57:2872.[Abstract/Free Full Text]
  8. Knigge, H., M. M. Simon, S. C. Meuer, M. D. Kramer, R. Wallich. 1996. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes. Eur. J. Immunol. 26:2299.[Medline]
  9. Ma, Y., J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell, mitogenic, and cytokine-stimulatory properties. Infect. Immun. 61:3843.[Abstract/Free Full Text]
  10. Morrison, T. B., J. H. Weis, J. J. Weis. 1997. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J. Immunol. 158:4838.[Abstract]
  11. Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J. Immunol. 147:1968.[Abstract]
  12. Radolf, J.D., L.L. Arndt, D.R. Akins, L.L. Curetty, M.E. Levi, Y. Shen, L.S. Davis, M.V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866.[Abstract]
  13. Vincent, M. S., K. Roessner, T. Sellati, C. D. Huston, L. H. Sigal, S. M. Behar, J. D. Radolf, R. C. Budd. 1998. Lyme arthritis synovial {gamma}{delta} T cells respond to Borrelial burgdorferi lipoproteins and lipidated hexapeptides. J. Immunol. 161:5762.[Abstract/Free Full Text]
  14. Wooten, R. M., V. R. Modur, T. M. McIntyre, J. J. Weis. 1996. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor NF-kB and inflammatory activation in human endothelial cells. J. Immunol. 157:4584.[Abstract]
  15. Sellati, T. J., L. D. Abrescia, J. D. Radolf, M. B. Furie. 1996. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect. Immun. 64:3180.[Abstract]
  16. Gupta, D., T. N. Kirkland, S. Viriyakosol, R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310.[Abstract/Free Full Text]
  17. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509.[Medline]
  18. Wright, S. D.. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6.[Medline]
  19. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, S. M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547.[Abstract]
  20. Simmons, D. L., S. Tan, D. G. Tenen, A. Nicholson-Weller, B. Seed. 1989. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73:284.[Abstract/Free Full Text]
  21. Zeigler-Heitbrock, H. W. L., R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121.[Medline]
  22. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665.[Abstract/Free Full Text]
  23. Haziot, A., G. W. Rong, J. Silver, S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500.[Abstract]
  24. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744.[Abstract/Free Full Text]
  25. Giambartolomei, G. H., V. A. Dennis, B. L. Lasater, M. T. Philipp. 1999. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect. Immun. 67:140.[Abstract/Free Full Text]
  26. Sellati, T. J., D. A. Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. M. Goyert, M. V. Norgard, J. D. Radolf. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that utilized by lipopolysaccharide. J. Immunol. 160:5455.[Abstract/Free Full Text]
  27. Wooten, R. M., T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, J. J. Weis. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:5485.[Abstract/Free Full Text]
  28. Jones, J. D., K. W. Bourell, M. V. Norgard, J. D. Radolf. 1995. Membrane topology of Borrelia burgdorferi and Treponema pallidum lipoproteins. Infect. Immun. 63:2424.[Abstract]
  29. Radolf, J. D.. 1995. Treponema pallidum and the quest for outer membrane proteins. Mol. Microbiol. 16:1067.[Medline]
  30. Shevchenko, D. V., T. J. Sellati, D. L. Cox, O. V. Shevchenko, E. J. Robinson, J. D. Radolf. 1999. Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog. Infect. Immun. 67:2266.[Abstract/Free Full Text]
  31. Defosse, D. L., R. C. Johnson. 1992. In vitro and in vivo induction of tumor necrosis factor {alpha} by Borrelia burgdorferi. Infect. Immun. 60:1109.[Abstract/Free Full Text]
  32. Riley, B. S., N. Oppenheimer-Marks, E. J. Hansen, J. D. Radolf, M. V. Norgard. 1992. Virulent Treponema pallidum activates human vascular endothelial cells. J. Infect. Dis. 165:484.[Medline]
  33. Sellati, T. J., M. J. Burns, M. A. Ficazzola, M. B. Furie. 1995. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect. Immun. 63:4439.[Abstract]
  34. Steere, A. C., R. L. Grodzicki, A. N. Kornblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. P. Schmid, E. Johnson, S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733.[Abstract]
  35. Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92:2909.[Abstract/Free Full Text]
  36. Radolf, J. D., N. R. Chamberlain, A. Clausell, M. V. Norgard. 1988. Identification and localization of integral membrane proteins of Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent Triton X-114. Infect. Immun. 56:490.[Abstract/Free Full Text]
  37. Akins, D. R., K. W. Bourell, M. J. Caimano, M. V. Norgard, J. D. Radolf. 1998. A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state. J. Clin. Invest. 101:2240.[Medline]
  38. Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Curetty, D. A. Harrich, J. D. Radolf. 1996. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-{kappa}B. Infect. Immun. 64:3845.[Abstract]
  39. O’Farrell, P. Z., H. M. Goodman, P. H. O’Farrell. 1977. High-resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 12:1133.[Medline]
  40. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171.[Medline]
  41. Pugin, J., V. V. Kravchenko, J.-D. Lee, L. Kline, R. J. Ulevitch, P. S. Tobias. 1998. Cell activation mediated by glycosylphosphotidylinositol-anchored or transmembrane forms of CD14. Infect. Immun. 66:1174.[Abstract/Free Full Text]
  42. Delude, R. L., A. Yoshimura, R. R. Ingalls, D. T. Golenbock. 1998. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF{alpha}, signal transduction. J. Immunol. 161:3001.[Abstract/Free Full Text]
  43. Viriyakosol, S., T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361.[Abstract/Free Full Text]
  44. de Silva, A. M., E. Fikrig. 1997. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 99:377.[Medline]
  45. Gupta, D., Y. Jin, R. Dziarski. 1995. Peptidoglycan induces transcription and secretion of TNF-{alpha} and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. J. Immunol. 155:2620.[Abstract]
  46. Kitchens, R. L., R. J. Ulevitch, R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485.[Abstract/Free Full Text]
  47. Martin, T. R., S. M. Mongovin, P. S. Tobias, J. C. Mathison, A. M. Moriarty, D. J. Leturcq, R. J. Ulevitch. 1994. The CD14 differentiation antigen mediates the development of endotoxin responsiveness during differentiation of mononuclear phagocytes. J. Leukocyte Biol. 56:1.[Abstract]
  48. Schwende, H., E. Fitzke, P. Ambs, P. Dieter. 1996. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukocyte Biol. 59:555.[Abstract]
  49. Zhang, D. E., C. J. Hetherington, D. A. Gonzalez, H. M. Chen, D. G. Tenen. 1994. Regulation of CD14 expression during monocytic differentiation induced with 1{alpha},25-dihydroxyvitamin D3. J. Immunol. 153:3276.[Abstract]
  50. Juan, T. S., E. Hailman, M. J. Kelley, S. D. Wright, H. S. Lichenstein. 1995. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J. Biol. Chem. 270:17237.[Abstract/Free Full Text]
  51. Stelter, F., M. Bernheiden, R. Menzel, R. S. Jack, S. Witt, X. L. Fan, Pfister, C. Schutt. 1997. Mutation of amino acids 39–44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur. J. Biochem. 243:100.[Medline]
  52. Viriyakosol, S., T. N. Kirkland. 1996. The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor. Infect. Immun. 64:653.[Abstract]
  53. Kitchens, R. L., P. W. Wang, R. S. Munford. 1998. Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J. Immunol. 161:5534.[Abstract/Free Full Text]
  54. Nikaido, H. 1996. Outer membrane. In Escherichia coli and Salmonella typhimurium Cellular and Molecular Biology, 2nd Ed. F. C. Neidhart, R. Curtiss, III, J. Ingraham, E. Lin, K. Low, B. Magasanik, W. Reznikoff, M. Riley, M. Schaechter, and H. Umbarger, eds. American Society for Microbiology, Washington, D.C., p. 29.
  55. Jack, R. S., W. Grunwald, F. Stelter, G. Workalemahu, C. Schütt. 1997. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria. Eur. J. Immunol. 25:1436.
  56. Katz, S. S., K. Chen, M. E. Doerfler, P. Elsbach, J. Weiss. 1996. Potent CD14-mediated signaling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect. Immun. 64:3592.[Abstract]
  57. Zhang, H., J. W. Peterson, D. W. Niesel, G. R. Klimpel. 1997. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159:4868.[Abstract]
  58. Benach, J. L., E. M. Bosler, J. P. Hanrahan, J. L. Coleman, G. S. Habicht, T. F. Bast, D. J. Cameron, J. L. Ziegler, A. G. Barbour, W. Burgdorfer, R. Edelman, R. A. Kaslow. 1983. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 308:740.[Abstract]
  59. Alder, J. D., L. Friess, M. Tengowski, R. F. Schell. 1990. Phagocytosis of opsonized Treponema pallidum subsp. pallidum proceeds slowly. Infect. Immun. 58:1167.[Abstract/Free Full Text]
  60. Lukehart, S. A., J. M. Shaffer, S. A. Baker-Zander. 1992. A subpopulation of Treponema pallidum is resistant to phagocytosis: possible mechanisms of persistence. J. Infect. Dis. 166:1449.[Medline]
  61. Ulevitch, R. J., P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437.[Medline]
  62. Kirschning, C. J., H. Wesche, T. M. Ayres, M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.[Abstract/Free Full Text]
  63. Medzhitov, R., P. Preston-Hurlburt, Jr C. A. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.[Medline]
  64. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
  65. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588.[Abstract/Free Full Text]
  66. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.[Medline]



This article has been cited by other articles:


Home page
Infect. Immun.Home page
O. S. Shin, R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu
Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction
Infect. Immun., June 1, 2008; 76(6): 2341 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Zhao, R. Fleming, B. McCloud, and M. S. Klempner
CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 by Borrelia burgdorferi
Infect. Immun., June 1, 2007; 75(6): 3062 - 3069.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. W. Moore, A. R. Cruz, C. J. LaVake, A. L. Marzo, C. H. Eggers, J. C. Salazar, and J. D. Radolf
Phagocytosis of Borrelia burgdorferi and Treponema pallidum Potentiates Innate Immune Activation and Induces Gamma Interferon Production
Infect. Immun., April 1, 2007; 75(4): 2046 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. M. Olson, M. N. Hedrick, H. Izadi, T. C. Bates, E. R. Olivera, and J. Anguita
p38 Mitogen-Activated Protein Kinase Controls NF-{kappa}B Transcriptional Activation and Tumor Necrosis Factor Alpha Production through RelA Phosphorylation Mediated by Mitogen- and Stress-Activated Protein Kinase 1 in Response to Borrelia burgdorferi Antigens
Infect. Immun., January 1, 2007; 75(1): 270 - 277.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. E. LaFond and S. A. Lukehart
Biological Basis for Syphilis
Clin. Microbiol. Rev., January 1, 2006; 19(1): 29 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. J. Caimano, C. H. Eggers, C. A. Gonzalez, and J. D. Radolf
Alternate Sigma Factor RpoS Is Required for the In Vivo-Specific Repression of Borrelia burgdorferi Plasmid lp54-Borne ospA and lp6.6 Genes
J. Bacteriol., November 15, 2005; 187(22): 7845 - 7852.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Q. Xu, S. V. Seemanapalli, L. Lomax, K. McShan, X. Li, E. Fikrig, and F. T. Liang
Association of Linear Plasmid 28-1 with an Arthritic Phenotype of Borrelia burgdorferi
Infect. Immun., November 1, 2005; 73(11): 7208 - 7215.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Al-Robaiy, J. Knauer, and R. K. Straubinger
Borrelia burgdorferi Organisms Lacking Plasmids 25 and 28-1 Are Internalized by Human Blood Phagocytes at a Rate Identical to That of the Wild-Type Strain
Infect. Immun., September 1, 2005; 73(9): 5547 - 5553.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R.-E.-I. Benhnia, D. Wroblewski, M. N. Akhtar, R. A. Patel, W. Lavezzi, S. C. Gangloff, S. M. Goyert, M. J. Caimano, J. D. Radolf, and T. J. Sellati
Signaling through CD14 Attenuates the Inflammatory Response to Borrelia burgdorferi, the Agent of Lyme Disease
J. Immunol., February 1, 2005; 174(3): 1539 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. J. Caimano, C. H. Eggers, K. R. O. Hazlett, and J. D. Radolf
RpoS Is Not Central to the General Stress Response in Borrelia burgdorferi but Does Control Expression of One or More Essential Virulence Determinants
Infect. Immun., November 1, 2004; 72(11): 6433 - 6445.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hashimoto, Y. Asai, and T. Ogawa
Treponemal Phospholipids Inhibit Innate Immune Responses Induced by Pathogen-associated Molecular Patterns
J. Biol. Chem., November 7, 2003; 278(45): 44205 - 44213.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. L. Coleman and J. L. Benach
The Urokinase Receptor Can Be Induced by Borrelia burgdorferi through Receptors of the Innate Immune System
Infect. Immun., October 1, 2003; 71(10): 5556 - 5564.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
W. C. Van Voorhis, L. K. Barrett, S. A. Lukehart, B. Schmidt, M. Schriefer, and C. E. Cameron
Serodiagnosis of Syphilis: Antibodies to Recombinant Tp0453, Tp92, and Gpd Proteins Are Sensitive and Specific Indicators of Infection by Treponema pallidum
J. Clin. Microbiol., August 1, 2003; 41(8): 3668 - 3674.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Anguita, S. W. Barthold, R. Persinski, M. N. Hedrick, C. A. Huy, R. J. Davis, R. A. Flavell, and E. Fikrig
Murine Lyme Arthritis Development Mediated by p38 Mitogen-Activated Protein Kinase Activity
J. Immunol., June 15, 2002; 168(12): 6352 - 6357.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. N. Fichorova, A. O. Cronin, E. Lien, D. J. Anderson, and R. R. Ingalls
Response to Neisseria gonorrhoeae by Cervicovaginal Epithelial Cells Occurs in the Absence of Toll-Like Receptor 4-Mediated Signaling
J. Immunol., March 1, 2002; 168(5): 2424 - 2432.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. A. Bouis, T. G. Popova, A. Takashima, and M. V. Norgard
Dendritic Cells Phagocytose and Are Activated by Treponema pallidum
Infect. Immun., January 1, 2001; 69(1): 518 - 528.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. K. Murthy, V. A. Dennis, B. L. Lasater, and M. T. Philipp
Interleukin-10 Modulates Proinflammatory Cytokines in the Human Monocytic Cell Line THP-1 Stimulated with Borrelia burgdorferi Lipoproteins
Infect. Immun., December 1, 2000; 68(12): 6663 - 6669.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-i. Shibata, A. Hasebe, T. Into, M. Yamada, and T. Watanabe
The N-Terminal Lipopeptide of a 44-kDa Membrane-Bound Lipoprotein of Mycoplasma salivarium Is Responsible for the Expression of Intercellular Adhesion Molecule-1 on the Cell Surface of Normal Human Gingival Fibroblasts
J. Immunol., December 1, 2000; 165(11): 6538 - 6544.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Lorenz, J. P. Mira, K. L. Cornish, N. C. Arbour, and D. A. Schwartz
A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection
Infect. Immun., November 1, 2000; 68(11): 6398 - 6401.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Lien, T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, et al.
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products
J. Biol. Chem., November 19, 1999; 274(47): 33419 - 33425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Opitz, N. W. J. Schroder, I. Spreitzer, K. S. Michelsen, C. J. Kirschning, W. Hallatschek, U. Zahringer, T. Hartung, U. B. Gobel, and R. R. Schumann
Toll-like Receptor-2 Mediates Treponema Glycolipid and Lipoteichoic Acid-induced NF-kappa B Translocation
J. Biol. Chem., June 15, 2001; 276(25): 22041 - 22047.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sellati, T. J.
Right arrow Articles by Radolf, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sellati, T. J.
Right arrow Articles by Radolf, J. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS